Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
INCB 086550 is an inhibitor of the protein-protein interaction between programmed cell death 1... more
Product information "INCB 086550"
INCB 086550 is an inhibitor of the protein-protein interaction between programmed cell death 1 (PD-1) and its ligand PD-L1. It inhibits PD-1 binding to PD-L1 in CHO cells expressing human PD-L1 (EC50 = 13.2 nM). INCB 086550 (1 µM) induces dimerization and internalization of PD-L1 in CHO cells expressing human PD-L1. It decreases the levels of unoccupied cell-surface PD-L1 in mouse MBT-2 bladder cancer cells expressing human PD-L1 at low, medium, or high levels (EC50s = 3.7, 0.4, and 0.1 nM, respectively). It prevents PD-1-induced recruitment of Src homology region 2 domain-containing phosphatase (SHP) in a reporter assay using Jurkat T cells co-cultured with U2OS cells expressing human PD-L1 (IC50 = 6.3 nM) and induces activation of nuclear factor of activated T cells (NFAT) in a reporter assay using Jurkat T cells co-cultured with CHO-K1 cells (IC50 = 21.4 nM). In vivo, INCB 086550 (20 or 200 mg/kg per day) reduces tumor volume and intratumoral cell-surface levels of PD-L1, as well as increases CD8+ T cell tumor infiltration, in an MC-38 murine allograft model of colon carcinoma overexpressing human PD-L1 (MC-38-hPD-L1).Formal Name: (3R)-1-[[7-cyano-2-[3'-[[3-[[(3R)-3-hydroxy-1-pyrrolidinyl]methyl]-1,7-naphthyridin-8-yl]amino]-2,2'-dimethyl[1,1'-biphenyl]-3-yl]-5-benzoxazolyl]methyl]-3-pyrrolidinecarboxylic acid. CAS Number: 2230911-59-6. Molecular Formula: C41H39N7O4. Formula Weight: 693.8. Purity: >98%. Formulation: (Request formulation change), A solid. Solubility: Ethanol: Soluble, Methanol: Soluble, Water: Soluble. SMILES: CC(C(C1=C(C(NC2=NC=CC3=C2N=CC(CN4CC[C@@H](O)C4)=C3)=CC=C1)C)=CC=C5)=C5C6=NC7=CC(CN8C[C@H](C(O)=O)CC8)=CC(C#N)=C7O6. InChi Code: InChI=1S/C41H39N7O4/c1-24-32(5-3-7-34(24)40-46-36-17-26(15-30(18-42)38(36)52-40)20-47-13-10-29(22-47)41(50)51)33-6-4-8-35(25(33)2)45-39-37-28(9-12-43-39)16-27(19-44-37)21-48-14-11-31(49)23-48/h3-9,12,15-17,19,29,31,49H,10-11,13-14,20-23H2,1-2H3,(H,43,45)(H,50,51)/t29-,31-/m1/s1. InChi Key: QARLNMDDSQMINK-BVRKHOPBSA-N.
Keywords: | (3R)-1-[[7-cyano-2-[3'-[[3-[[(3R)-3-hydroxy-1-pyrrolidinyl]methyl]-1,7-naphthyridin-8-yl]amino]-2,2'-dimethyl[1,1'-biphenyl]-3-yl]-5-benzoxazolyl]methyl]-3-pyrrolidinecarboxylic acid |
Supplier: | Cayman Chemical |
Supplier-Nr: | 38781 |
Properties
Application: | PD-1/PD-L1 interaction inhibitor |
MW: | 693.8 D |
Formula: | C41H39N7O4 |
Purity: | >98% |
Format: | Solid |
Database Information
CAS : | 2230911-59-6| Matching products |
KEGG ID : | K06745 | Matching products |
Handling & Safety
Storage: | -20°C |
Shipping: | +20°C (International: -20°C) |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow.
more
You will get a certificate here
Viewed